-
April 15, 2020 Lupin’s Mandideep Unit II Facility Receives EIR from U.S. FDA
-
April 13, 2020 Lupin’s Nagpur Facility Receives EIR from U.S. FDA
-
April 11, 2020 Lupin Contributes INR 21 crores Towards COVID-19 Relief Efforts
-
April 6, 2020 LuaLupin launches Mycophenolic Acid Delayed-Release Tablets USP
-
April 3, 2020 Lupin’s Aurangabad Facility Receives EIR from U.S. FDA
-
March 30, 2020 Lupin’s Inhalation Research Center, Florida receives EIR from U.S. FDA
-
March 27, 2020 Lupin and Mylan announce Positive European Medicines Agency opinion recommending Approval of Nepexto®, Biosimilar Etanercept
-
March 26, 2020 Lupin Appoints Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs
-
March 20, 2020 Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications